Asset Details
Do you wish to reserve the book?
Intrauterine G-CSF Administration in Recurrent Implantation Failure (RIF): An Rct
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Intrauterine G-CSF Administration in Recurrent Implantation Failure (RIF): An Rct
Do you wish to request the book?
Intrauterine G-CSF Administration in Recurrent Implantation Failure (RIF): An Rct
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Intrauterine G-CSF Administration in Recurrent Implantation Failure (RIF): An Rct
2020
Overview
This study investigates the effects of intrauterine G-CSF on endometrial thickness, clinical pregnancy rate and live birth rate in a recurrent implantation failure (RIF) group with normal endometrium. This study was designed as a prospective randomized controlled trial with the involvement of 157 RIF group pati; ents. The RIF group was formed on the basis of the RIF criteria: “The failure to achieve a clinical pregnancy after the transfer of at least four good-quality embryos in a minimum of three fresh or frozen cycles to a woman under the age of 40 years. The study sample included 82 patients in the G-CSF group who received G-CSF once a day on hCG. The procedure was performed by administering 30 mIU of Leucostim®(Filgrastim [G-CSF] 30 mIU/mL; DEM Medical, Dong-A; South Korea) through slow infusion into the endometrial cavity using a soft embryo transfer catheter. Normal saline of 1 mL was infused into the endometrial cavity in the same way in 75 patients in the control group. The standard ICSI procedure was used for all patients, and fresh cycle embryos were transferred on the third or fifth day. No statistically significant difference was identified in clinical pregnancy rates, miscarriage rates and live birth rates between the G-CSF group and the control group (p = 0.112, p = 0.171, p = 0.644, respectively), and no difference was observed between the two groups regarding endometrial thickness (p = 0.965). The intervention of administration G-CSF into the uterine cavity in RIF patients with normal endometrium, did not alter the endometrial thickness, clinical pregnancy rates, or live birth rates.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ Adult
/ Biological Therapy - methods
/ Births
/ Embryo Implantation - drug effects
/ Embryos
/ Female
/ Filgrastim - therapeutic use
/ Granulocyte colony-stimulating factor
/ Humanities and Social Sciences
/ Humans
/ Infertility, Female - drug therapy
/ Lenograstim - therapeutic use
/ Patients
/ Reproductive Techniques, Assisted
/ Science
/ Uterus
